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Abstract  Giant  cell  arteritis  (GCA)  is  a  systemic  large  vessel  vasculitis,  with  extracranial  arte-
rial involvement  described  in 10--15%  of  cases,  usually  affecting  the  aorta  and its  branches.
Patients  with  GCA  are  more  likely  to  develop  aortic  aneurysms,  but  these  are  rarely  present  at
the time  of  the  diagnosis.
We  report  the  case  of  an  80-year-old  Caucasian  woman,  who  reported  proximal  muscle  pain  in
the arms  with  morning  stiffness  of  the  shoulders  for  eight  months.  In  the  previous  two  months,
she had  developed  worsening  bilateral  arm  claudication,  severe  pain,  cold  extremities  and
digital necrosis.  She had  no palpable  radial  pulses  and  no  measurable  blood  pressure.
The  patient  had  normochromic  anemia,  erythrocyte  sedimentation  rate  of  120  mm/h,  and
a negative  infectious  and  autoimmune  workup.  Computed  tomography  angiography  revealed
concentric wall  thickening  of  the  aorta  extending  to  the  aortic  arch  branches,  particularly  the
subclavian and  axillary  arteries,  which  were  severely  stenotic,  with  areas  of  bilateral  occlusion
and an  aneurysm  of the  ascending  aorta  (47  mm).  Despite  corticosteroid  therapy  there  was
progression  to  acute  critical  ischemia.  She  accordingly  underwent  surgical  revascularization
using a  bilateral  carotid-humeral  bypass.  After  surgery,  corticosteroid  therapy  was  maintained
and at six-month  follow-up  she  was  clinically  stable  with  reduced  inﬂammatory  markers.
GCA,  usually  a chronic  benign  vasculitis,  presented  exceptionally  in  this  case  as acute  critical
upper limb  ischemia,  resulting  from  a  massive  inﬂammatory  process  of  the  subclavian  and
axillary arteries,  treated  with  salvage  surgical  revascularization.
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PALAVRAS-CHAVE
Arterite  de  células
gigantes;




Isquemia  crítica  dos membros  superiores,  uma  apresentac¸ão rara  de  arterite
de  células  gigantes
Resumo  A  arterite  de  células  gigantes  (ACG)  é uma  vasculite  de  grandes  vasos,  com  envolvi-
mento extracraniano  em  10-15%  dos  casos,  afetando  preferencialmente  a  aorta  e  os  seus  ramos.
Os aneurismas  da  aorta  ascendente  são  mais  frequentes  em  doentes  com  ACG,  mas  são  raros
no momento  do  diagnóstico.
Apresentamos  o  caso  de uma  doente,  caucasiana,  com  80  anos  de idade,  que  descrevia  dor
muscular  nos  membros  superiores,  com  rigidez  matinal  dos  ombros,  desde  há  oito  meses.  Nos
últimos dois  meses  referia  claudicac¸ão  intermitente  de agravamento  progressivo,  dor  intensa,
extremidades  frias  e o  aparecimento  de  úlceras  digitais.  Ao  exame  objetivo  não  se  palpavam
pulsos radiais  ou  cubitais,  nem  se  registavam  valores  de  pressão  arterial.
Laboratorialmente,  destacava-se  anemia  normocíticanormocrómica,  VS  de  120  mm/h  e
estudo autoimune  e infeccioso  negativos.  A tomograﬁa  computorizada  com  contraste  revelou
espessamento concêntrico  da parede  da  aorta  e  dos  seus  ramos,  notoriamente  artéria  subclávia
e axilar,  que  apresentavam  áreas  de estenose  e oclusão  bilaterais  e uma  dilatac¸ão  aneurismática
da aorta  ascendente  (47  mm).  Apesar  da  instituic¸ão  imediata  de  corticoterapia,  veriﬁcou-se
uma progressão  para  isquemia  crítica  aguda  dos  membros  superiores.  Consequentemente,  foi
submetida com  sucesso  a  revascularizac¸ão  cirúrgica  através  de um bypass  carótido-umeral.
A doente  manteve  corticoterapia  e  ao  6.◦ mês  de follow-up  encontrava-se  clinicamente  estável,
com regressão  dos  parâmetros  inﬂamatórios.
A ACG  é habitualmente  descrita  como  uma  patologia  indolente  e benigna.  No entanto,
apresentou-se neste  caso  como  uma  isquemia  crítica  aguda  dos  membros  superiores,  secundária
à intensa  resposta  inﬂamatória  das  artérias  subclávias  e axilares,  obrigando  à  revascularizac¸ão
cirúrgica.
© 2016  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos  os
direitos reservados.
Introduction
Giant  cell  arteritis  (GCA)  is  a systemic  medium  and  large  ves-
sel  vasculitis,  with  a wide spectrum  of  presentations,  most
frequently  secondary  to  involvement  of the  cranial  arter-
ies,  the  typical  symptoms  being  headache,  jaw claudication,
visual  loss  and  stroke.  Extracranial  arterial  involvement  is
described  in 10--15%  of  cases,1,2 usually  presenting  as  upper
or  lower  extremity  claudication,  and  rarely  with  acute  crit-
ical  ischemia  as  the  primary  ﬁnding.
We  report  a severe  and  sudden  case  of  acute  critical
ischemia  of  the arms  with  digital  necrosis  as  the  presenting
features  of  GCA,  successfully  treated  by  salvage  revascu-
larization  surgery.  Only  large vessels  were  involved,  mainly
the  subclavian  and axillary  arteries,  with  no  involvement
of  the  carotid  or  cranial  arteries.
Case  report
An  80-year-old  Caucasian  woman  with  a  history  of hyper-
tension  described  proximal  muscle  pain  in the  arms  with
morning  stiffness  of  the  shoulders  and  neck,  for the  past
eight  months.  In the previous  two  months, she  had  devel-
oped  worsening  bilateral  arm  claudication,  severe  pain  with
restricted  mobility,  cold  extremities  and  digital  necrosis.
She  had  no  palpable  radial  or  cubital  pulses  and  no  measur-
able  blood  pressure.  There  were no  clinical  signs  of  cranial  or
lower  limb  artery  involvement  and  no  constitutional  symp-
toms  were  reported.
Investigation
The  patient  presented  normochromic  anemia,  elevated
erythrocyte  sedimentation  rate  (ESR)  (120  mm/h)  and  C-
reactive  protein  (CRP)  (123  mg/l),  and  negative  infectious
and  autoimmune  workup.  Contrast  computed  tomogra-
phy  angiography  (CTA) in the  arterial  phase  (Figures  1--3)
revealed  concentric  wall  thickening  of  the  aorta  extend-
ing  to  the  aortic  arch  branches, particularly  the  subclavian
and  axillary  arteries,  which  were  severely  stenotic  with
areas  of  bilateral  luminal  occlusion,  and  no  involvement  of
the  carotid  branches;  an aneurysm  of  the ascending  aorta
47  mm in diameter  was  also  detected.
The  patient  immediately  started  corticosteroid  ther-
apy  (prednisone  1  mg/kg  daily)  and  aspirin  (100  mg
Figure  1  Concentric  wall  thickening  of  the  left  subclavian
artery.
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Figure  2  Stenotic  lesions  in the  right  subclavian  artery  (max-
imum intensity  projection  reconstruction).
Figure  3  Stenotic  lesions  in the left  subclavian  artery  (maxi-
mum intensity  projection  reconstruction).
daily),  but  there  was  incomplete  resolution  of the symp-
toms  with  progression  of  digital  ulceration,  necrosis  and
paresthesia,  features  of acute  critical  ischemia.  Surgical
revascularization  using  a  bilateral  carotid-humeral  bypass
was  accordingly  performed.
After  surgery,  corticosteroid  therapy  was maintained
(slowly  tapered  to  40  mg/day),  and  at  the  six-month  follow-
up  appointment,  there  was  no  arm  claudication  and on
physical  examination  there  were  palpable  radial  and cubital
pulses  and  systolic  blood  pressure  of  135 mmHg.  Laboratory
exams  revealed  a sustained  reduction  of  serum  inﬂamma-
tory  markers,  and  follow-up  CTA  (Figure  4)  showed  adequate
permeability  of  the bypassed  vessels  and stability  of  the
aneurysm.  The  histological  result  of  the biopsied  artery
showed  a  transmural  inﬂammatory  inﬁltrate.
Discussion
Giant cell arteritis  is  a  chronic  inﬂammatory  systemic
disease,  affecting  medium  and  large arteries.  The  most  com-
mon  symptoms  arise  from  the preferential  involvement  of
the  cranial  arteries,  especially  branches  of the external
carotid  such  as the temporal  or  ophthalmic  artery.
Figure  4  Bilateral  carotid-humeral  bypass  at six-month
follow-up  (volume  rendering).
In 10--15% of  patients  there  is  involvement  of  aortic  arch
branches,  particularly  the subclavian  and  axillary  arteries.1,2
This  involvement  is  rarely  the presenting  feature  of  the
disease,  usually  resulting  from  progression  or  relapse  after
discontinuation  or  tapering  of corticosteroid  therapy.1 One
study  reported  a period  of  eleven  months  between  diagno-
sis  of  temporal  artery  GCA  and  the appearance  of  symptoms
resulting  from  involvement  of  the  upper  limb  arteries.3 The
most  common  symptom  of  such  involvement  is  arm claudi-
cation  and  pain  (68%),  but  in rare  cases  it can  evolve  into
critical  ischemia,  digital  ulceration  and  gangrene.1
Unlike for  temporal  artery  GCA,  there  are no  validated
independent  criteria  for  the diagnosis  of  GCA  with  involve-
ment  of  the upper  limb  arteries,  so  this  relies on  clinical
suspicion,  supported  by  laboratory  and  imaging  studies.  An
ESR  of over  50  mm/h  was  one  of  the  ﬁrst  inﬂammatory
markers  associated  with  the  disease,  and  is part  of  the
American  College  of  Rheumatology  criteria  for  GCA  diagno-
sis  (86.5%  sensitivity  and  47.7%  speciﬁcity).4 Some  studies
of  GCA  with  upper  or  lower  limb  involvement  found lower
ESR  values  compared  with  temporal  artery  GCA.1 CRP  level
was  observed  to  be a more  sensitive  marker  of  disease
activity,  and is  especially  useful  to  access  disease  relapse.2
The  European  League  Against  Rheumatism  guidelines  for  the
management  of  GCA  recommend  a temporal  artery  biopsy
in  all  patients  whenever  a diagnosis  is  suspected  (level  of
evidence  3,  strength  of recommendation  C).5 Nevertheless,
Brack  et al.  reported  negative  temporal  artery  biopsy  in
42%  of patients  with  large-vessel  GCA.6 Assie et al.  also
observed  a lower  rate  of  positive  temporal  artery  biopsy  in
patients  with  temporal  artery GCA  compared  to  those  with
involvement  of  upper  and  lower  limb  arteries  (69%  vs.  95%).7
Biopsy  of  the affected  artery is  generally  only available  if
revascularization  procedures  take  place,  so the diagnosis
and  treatment  strategy  of  large-vessel  GCA are frequently
decided  before  histological  results  are available.  The  biopsy
may  reveal  transmural  inﬂammatory  inﬁltrate  with  fragmen-
tation  of  the elastic  lamina  with  or  without  giant  cells  in a
focal  and  segmental  distribution.  False  negatives  are possi-
ble  depending  on  the sample  size  (ideally  1--2  cm),  duration
of  previous  corticosteroid  therapy  and  the presence  of skip
lesions.  CTA  is  an excellent  non-invasive  exam  to  assess
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vessel  wall  thickness  and  regularity,  also  revealing  luminal
defects  such  as  stenosis,  occlusion,  dilation  and  aneurysms.
As  a  systemic  inﬂammatory  disease  the ﬁrst-line  treat-
ment  advocated  in  most  guidelines  is  corticosteroid  therapy
(1  mg/kg/day,  maximum  60  mg  daily),  with  some  authors
suggesting  high-dose  methylprednisolone  bolus  before  oral
corticosteroid  therapy.  Nonetheless,  there  is  scant  evidence
supporting  this  strategy  in  GCA patients  with  upper  limb
artery  involvement.  Our  patient  immediately  started  pred-
nisone  60  mg/d,  and  showed  a  slight  clinical  improvement
within  days.  However,  the bilateral  occlusion  of  both  sub-
clavian  arteries  was  remarkably  severe,  and progression  to
critical  ischemia  was  inevitable.  The  vascular  surgery  team
performed  a  bilateral  carotid-humeral  bypass  as a salvage
revascularization  procedure  to  assure  blood  ﬂow  and  limb
viability.  She  continued  corticosteroid  therapy  with  slow
dose  tapering.  Surgical  intervention  in such  patients  is  rarely
indicated  because  of  the chronic  nature of  the  disease.
Nonetheless,  when the occlusion  is  abrupt  there  is  no  time  to
develop  collateral  circulation  to  assure  tissue  viability  and
the  response  to  corticosteroids  can be  inadequate,  espe-
cially  in  cases  of  large  vessel  involvement.8 There  are  some
small  series  reporting  the use  of  balloon  angioplasty  as  a
minimally  invasive  revascularization  procedure,  with  excel-
lent  immediate  results  but  with  50%  recurrence  of stenosis
after  a  median  of  ﬁve  months.9
Follow-up  in  these  patients  is  mainly  based on the
response  to  corticosteroid  therapy,  as assessed  by  clinical
evolution,  reduction  in inﬂammatory  markers  and, in  some
cases,  imaging  studies.  A  treatment  course  of  one  to  two
years  is  often  required,  but  some  patients  have a more
chronic  or  relapsing  course of  the  disease  and  require  longer
treatment.
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